Upfront Immunotherapy for Metastatic Kidney Cancer

0 Views
administrator
administrator
06/26/23

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next